Will Molecular Biology's Most Important Discovery In Years Be Ruined By Patents?
|
|
CRISPR-Cas can be thought of as the first really powerful and general-purpose genome editor -- a GNU Emacs for DNA. It is widely expected that it will have a massive impact on molecular biology, both for pure research and in industrial applications. Given those very high stakes, it will not come as a surprise to learn that there is already a fierce tussle over who owns a key patent in this field:
|
|
Full Story |
This topic does not have any threads posted yet!
You cannot post until you login.
